bioAffinity Technologies, Inc.

BIAF ·Healthcare, Diagnostics & Research, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Oct 23, 2026 DEF 14A
8-K Oct 15, 2026 8-K
8-K Oct 13, 2026 8-K
PRER14A Oct 13, 2026 PRER14A
8-K Oct 9, 2026 8-K
424B5 Oct 9, 2026 424B5
424B5 Oct 9, 2026 424B5
8-K Oct 8, 2026 8-K
8-K Oct 6, 2026 8-K
8-K Sep 30, 2026 8-K
PRE 14A Sep 29, 2026 PRE 14A
8-K Sep 22, 2026 8-K
8-K Sep 17, 2026 8-K
8-K Sep 11, 2026 8-K
8-K Sep 9, 2026 8-K
424B3 Sep 8, 2026 424B3
EFFECT Sep 4, 2026
8-K Sep 3, 2026 8-K
S-3/A Sep 3, 2026 S-3/A
8-K Sep 1, 2026 8-K
S-3 Aug 27, 2026 S-3
8-K Aug 20, 2026 8-K
8-K Aug 18, 2026 8-K
8-K Aug 14, 2026 8-K
10-Q Aug 7, 2026 10-Q
← Newer Page 1 of 16 · 396 filings Older →